Envista Holdings Corp
NYSE:NVST

  • LAST PRICE
    19.1700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    18.0100/ 2
  • Ask / Lots
    20.0400/ 1
  • Open / Previous Close
    0.0000 / 19.1700
  • Day Range
    ---
  • 52 Week Range
    18.0900
    36.1400
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
NVST
Envista Holdings Corp
3.3B
-26.9x
---
ICUI
ICU Medical Inc
2.6B
-42.9x
---
ENOV
Enovis Corp
2.9B
-27.8x
---
LIVN
LivaNova PLC
3.3B
-103.9x
---
TXG
10X Genomics Inc
3.2B
-11.9x
---
NEOG
Neogen Corp
2.8B
1,815.5x
---
As of 2024-05-15

Company Information

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Contact Information

Headquarters
200 S. Kraemer Blvd., Bldg. EBREA, CA, United States 92821
Phone
714-817-5418
Fax
302-655-5049

Executives

Independent Chairman of the Board
Scott Huennekens
President, Chief Executive Officer, Director
Paul Keel
Principal Financial Officer
Stephen Keller
President - Diagnostics
Robert Befidi
Senior Vice President, General Counsel, Secretary
Mark Nance

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$3.3B
Revenue (TTM)
$2.6B
Shares Outstanding
171.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.34
EPS
$-0.71
Book Value
$24.34
P/E Ratio
-26.9x
Price/Sales (TTM)
1.3
Price/Cash Flow (TTM)
302.2x
Operating Margin
0.29%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.